BNP Paribas Aktienanleihe MRK 27..../ DE000PC06J95 /
2024-05-31 9:40:20 PM | Chg.+0.050 | Bid9:46:59 PM | Ask9:46:59 PM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
101.380EUR | +0.05% | 101.390 Bid Size: 20,000 |
101.490 Ask Size: 20,000 |
MERCK KGAA O.N. | 150.00 - | 2024-06-27 | Call |
GlobeNewswire
05-31
Medicenna To Present Evidence of Durable Single Agent Activity and Potent Immune Effector Response w...
GlobeNewswire
05-29
Jeito Capital announces the acquisition by Merck & Co (NYSE: MRK) of its portfolio company EyeBio fo...
GlobeNewswire
05-07
CytomX Therapeutics Announces Clinical Collaboration with Merck to Evaluate CX-801 in Combination wi...
GlobeNewswire
05-06
Press Release Biocartis NV: Biocartis and Merck to Collaborate on Improving Patient Access to Person...
GlobeNewswire
03-04
C4 Therapeutics Announces Strategic Discovery Research Collaboration with Merck KGaA, Darmstadt, Ger...
GlobeNewswire
2023-12-21
Arch Biopartners Receives Approval from Ethics Committee in Turkey to Proceed with Phase II Cardiac ...
GlobeNewswire
2023-12-14
ITM Executes License Agreement to Obtain Worldwide Exclusive License for the Clinical Development an...
GlobeNewswire
2023-10-17
ImmunOs Therapeutics Announces Clinical Trial Collaboration with Merck & Co., Inc., Rahway, NJ, USA